These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22732702)

  • 1. Safety of hematopoietic stem cell donation in glucose 6 phosphate dehydrogenase-deficient donors.
    Pilo F; Baronciani D; Depau C; Targhetta C; Pani M; Manconi R; Fadda MG; Mamusa AM; Angelucci E
    Bone Marrow Transplant; 2013 Jan; 48(1):36-9. PubMed ID: 22732702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-6-phosphate dehydrogenase deficiency and hematopoietic stem cell transplantation.
    Au WY; Ma SK; Lie AK; Liang R; Cheng T; Kwong YL
    Bone Marrow Transplant; 2002 Mar; 29(5):399-402. PubMed ID: 11919729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors.
    Rinaldi C; Savignano C; Pasca S; Sperotto A; Patriarca F; Isola M; Fanin R; De Angelis V
    Transfusion; 2012 Nov; 52(11):2387-94. PubMed ID: 22452363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
    Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
    Heldal D; Brinch L; Tjønnfjord G; Solheim BG; Egeland T; Gadeholt G; Albrechtsen D; Aamodt G; Evensen SA
    Bone Marrow Transplant; 2002 Mar; 29(6):479-86. PubMed ID: 11960266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors.
    Au WY; Pang A; Lam KK; Song YQ; Lee WM; So JC; Kwong YL
    Bone Marrow Transplant; 2007 Oct; 40(7):677-81. PubMed ID: 17660836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y; Takaue Y; Watanabe T; Abe T; Okamoto Y; Iwai A; Iwai T; Watanabe A; Ito E; Makimoto A; Nakagawa R; Watanabe H; Sato J; Suenaga K; Suzuya H; Ohnishi T; Kanamaru S; Kaneko M; Kuroda Y
    Cancer Res; 1999 Jul; 59(14):3321-4. PubMed ID: 10416586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
    Elfenbein GJ
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
    Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
    Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
    Anderlini P; Rizzo JD; Nugent ML; Schmitz N; Champlin RE; Horowitz MM; ;
    Bone Marrow Transplant; 2001 Apr; 27(7):689-92. PubMed ID: 11360107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell mobilization with G-CSF.
    Hosing C
    Methods Mol Biol; 2012; 904():37-47. PubMed ID: 22890920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.